Clinical trial
An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat…
NCT00270569 · Far Eastern Memorial Hospital, Other · Unknown status
Key facts
| NCT number | NCT00270569 |
|---|---|
| Title | An Effective and Compliance Regimen of Paclitaxel Plus Cisplatin to Treat Metastatic Breast Cancer |
| Official title | A Phase II Study of Weekly Low-Dose Paclitaxel Plus 24-Hour Infusion of Cisplatin as First-Line Chemotherapy for Metastatic Breast Cancer |
| Lead sponsor | Far Eastern Memorial Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Neoplasms |
| Intervention type | Drug |
| Interventions | PhyxolTM, Cisplatin |
| Enrollment | 43 |
| Start date | Oct 1, 2005 |
| Primary completion | Feb 1, 2007 |
| First posted | Dec 28, 2005 |
| Last update posted | Feb 9, 2009 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: